Avoid Rivaroxaban for VTE Prophylaxis in Medical Patients
December 2019
A new rivaroxaban (Xarelto) indication will raise questions about inpatient and extended venous thromboembolism (VTE) prophylaxis.
You'll hear reps promote rivaroxaban 10 mg/day for VTE prophylaxis in MEDICAL inpatients...AND after discharge for up to 39 days total.
But point out the limitations with this new indication.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote